|
Jul 24
|
Qiagen N.V.'s (NYSE:QGEN) high institutional ownership speaks for itself as stock continues to impress, up 4.3% over last week
|
|
Jul 23
|
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term
|
|
Jul 22
|
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels
|
|
Jul 22
|
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?
|
|
Jul 1
|
Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?
|
|
Jun 26
|
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
|
|
Jun 26
|
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
|
May 10
|
The Qiagen N.V. (NYSE:QGEN) First-Quarter Results Are Out And Analysts Have Published New Forecasts
|
|
May 7
|
QIAGEN announces plans for transition in leadership of Supervisory Board
|
|
May 7
|
QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase
|
|
May 7
|
QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting
|
|
Mar 3
|
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
|
|
Feb 14
|
Institutional owners may take dramatic actions as Qiagen N.V.'s (NYSE:QGEN) recent 5.6% drop adds to one-year losses
|
|
Feb 13
|
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
|